Estrogen and/or calcium plus vitamin D increase mandibular bone mass

Journal of Periodontology

Volumn 75, Issue 6, 2004, Pages 811-816

  Hildebolt, Charles F ^a   Pilgram, Thomas K ^a   Dotson, Mary ^b   Armamento Villareal, Reina ^a   Hauser, Jay ^b   Cohen, Sheldon ^b   Civitelli, Roberto ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Alveolar bone; Bone density; Estrogen replacement therapy; Follow up studies; Hormone replacement therapy; Risk factors

Indexed keywords

CALCIUM; ESTROGEN; MEDROXYPROGESTERONE; PLACEBO; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; FEMALE; HORMONE SUBSTITUTION; HUMAN; MANDIBLE; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SIDE EFFECT;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; BONE DENSITY; CALCIUM; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MANDIBLE; MANDIBULAR DISEASES; MIDDLE AGED; POSTMENOPAUSE; VITAMIN D;

EID: 3543043197     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.6.811     Document Type: Article

References (28)

1. Elders PJ, Netelenbos JC, Lips P, van Ginkel FC, van der Stelt PF. Accelerated vertebral bone loss in relation to the menopause: A cross-sectional study on lumbar bone density in 286 women of 46 to 55 years of age. Bone Miner 1988;5:11-19.
2. Christiansen C, Mazess RB, Transbol I, Jensen GF. Factors in response to treatment of early postmenopausal bone loss. Calcif Tissue Int 1981;33:575-581.
3. Wactawski-Wende J, Grossi SG, Tevisan M, et al. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 1996;67:1076-1084.
4. Jeffcoat MK, Reddy MS, DeCarlo AA. Oral bone loss and systemic osteopenia. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. New York: Academic Press; 1996:969-990.
5. Hildebolt CF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol 1997;26:3-15.
6. Southard KA, Southard TE, Schlechte JA, Meis PA. The relationship between the density of the alveolar processes and that of post-cranial bone. J Dent Res 2000;79:964-969.
7. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000;71:1492-1498.
8. von Wowern N. General and oral aspects of osteoporosis: A review. Clin Oral Investig 2001;5:71-82.
9. White SC. Oral radiographic predictors of osteoporosis. Dentomaxillofac Radiol 2002;31:84-92.
10. Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996;276:1389-1396.
11. Heaney RP. The importance of calcium intake for life-long skeletal health. Calcif Tissue Int 2002;70:70-73.
12. Civitelli R, Pilgram TK, Dotson M, et al. Hormone/estrogen replacement therapy improves alveolar and postcranial bone density in postmenopausal women. Arch Intern Med 2002;162:1409-1415.
13. Hildebolt CF, Brunsden B, Yokoyama-Crothers N, et al. Comparison of reliability of radiodensity measures of alveolar bone loss performed with manual and computer intensive methods. Dentomaxillofac Radiol 1998;27:245-250.
14. Leelawattana R, Ziambaras K, Roodman-Weiss J, et al. The oxidative metabolism of estradiol conditions post-menopausal bone density and bone loss. J Bone Miner Res 2000;15:2513-2520.
15. Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 1985;312:283-289.
16. Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes (DRI) for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Standing Committee on the Scientiflc Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Washington, DC: National Academy Press; 1997:134-143, 278-286.
17. Cumming RG. Calcium intake and bone mass: A quantitative review of the evidence. Calcif Tissue Int 1990;47: 194-201.
18. Tilyard MW, Spears GF, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-362.
19. Chen JT, Shiraki M, Hasumi K, et al. 1-alpha-hydroxy-vitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early post-menopausal women. Bone 1997;20:557-562.
20. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-676.
21. Nishida M, Grossi SG, Dunford RG, Ho AW, Trevisan M, Genco RJ. Calcium and the risk for periodontal disease. J Periodontol 2000;71:1057-1066.
22. Krall EA, Wehler C, Garcia RI, Harris SS, Dawson-Hughes B. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 2001;111:452-456.
23. Krall EA. The periodontal-systemic connection: Implications for treatment of patients with osteoporosis and periodontal disease. Ann Periodontol 2001;6:209-213.
24. Gillespie WJ, Avenell A, Henry DA, O'Connell DL, Robertson J. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Cochrane Review). In: The Cochrane Library, issue 4, 2002. Oxford: Update Software.
25. Shea B, Wells G, Cranney A, Zytaruk N, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002;23:552-559.
26. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002;288:49-57.
27. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
28. Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999;353:571-580.